BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Charles Hsu will be a keynote speaker at the annual meeting of the Sino-American Pharmaceutical Association (West) in San Francisco
News | 04. 15. 2006
